Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its own once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) develo...

Daiichi pays out Merck $170M to form lung cancer cells T-cell engager contract

.Merck &amp Co. has rapidly recouped several of the costs of its Spear Therapeutics purchase, drawin...

BioMarin halts preclinical gene treatment for heart disease

.After BioMarin conducted a spring season well-maintained of its own pipeline in April, the provider...

Eisai vegetations molecular glue SEED with $1.5 B biobucks deal

.Large Pharmas remain caught to the idea of molecular glue degraders. The latest firm to view an opt...

Life science credit history company reveals with $600M

.A brand-new international lifestyle scientific research credit scores organization, called Symbioti...

BMS ditches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more major wager from the Caforio age, ending a package ...

Nuvation stops wager prevention after considering stage 1 data

.After having a look at period 1 data, Nuvation Bio has made a decision to halt service its own sing...

' Professional instinct' led FDA specialists to support Zevra's rare condition med

.Zevra Rehabs' uncommon illness medication seems to become on the road to authorization this loss af...

Pfizer takes $230M hit after axing failed DMD genetics treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has actually gone a $23...

AC Immune sees 'landmark' potential in Alzheimer's medicine information

.After greater than 20 years of work on neurodegenerative health conditions, Swiss biotech a/c Immun...